Stock Track | Vita Coco (COCO) Soars 9.04% Pre-market on Strong Q3 Results and Raised Guidance

Stock Track
Oct 29, 2025

Shares of The Vita Coco Company, Inc. (COCO) surged 9.04% in pre-market trading on Wednesday following the release of its impressive third-quarter 2025 financial results and raised full-year guidance. The coconut water retailer demonstrated strong growth and beat analyst expectations, driving investor enthusiasm.

Vita Coco reported net sales of $182 million for Q3, representing a substantial 37% increase from the prior year period and surpassing the analyst consensus estimate of $155.36 million. The company's flagship product, Vita Coco Coconut Water, was a key driver of this growth, with net sales climbing 42% in the quarter. Net income for Q3 rose to $24 million, up from $19 million in the same period last year, while earnings per share reached $0.40, beating the analyst estimate of $0.29.

In light of the strong performance, Vita Coco raised its full-year 2025 guidance. The company now expects net sales to be between $580 million and $595 million, with adjusted EBITDA projected in the range of $90 million to $95 million. This optimistic outlook, coupled with the robust Q3 results, has fueled investor confidence in Vita Coco's growth trajectory. The pre-market stock surge reflects the market's positive reaction to the company's ability to capitalize on the growing demand for coconut water and its strong execution in key markets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10